ARIPIPRAZOLE-AU aripiprazole 5 mg tablet bottle

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

即購入

公開評価報告書 公開評価報告書 (PAR)
26-11-2017

有効成分:

aripiprazole, Quantity: 5 mg

から入手可能:

Medis Pharma Pty Ltd

INN(国際名):

aripiprazole

医薬品形態:

Tablet, uncoated

構図:

Excipient Ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; maize starch; hyprolose

投与経路:

Oral

パッケージ内のユニット:

100, 250

処方タイプ:

(S4) Prescription Only Medicine

適応症:

Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,Acute treatment of manic or mixed episodes associated with Bipolar I Disorder in adults as monotherapy and in combination with lithium or valproate;,Maintenance treatment of manic or mixed episodes in Bipolar I Disorder in adults as monotherapy.

製品概要:

Visual Identification: 5 mm, round, biconvex, white uncoated tablets with 5 debossed on one side and ZL on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

認証ステータス:

Licence status A

承認日:

2014-10-29